150 related articles for article (PubMed ID: 27137421)
1. Guideline adherence for mentally ill reproductive-aged women on treatment with valproic acid: a retrospective chart review.
Gotlib D; Perelstein E; Kurlander J; Zivin K; Riba M; Muzik M
J Clin Psychiatry; 2016 Apr; 77(4):527-34. PubMed ID: 27137421
[TBL] [Abstract][Full Text] [Related]
2. Should women of childbearing potential be prescribed valproate? a call to action.
Balon R; Riba M
J Clin Psychiatry; 2016 Apr; 77(4):525-6. PubMed ID: 27137420
[TBL] [Abstract][Full Text] [Related]
3. Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate.
Craig J; Morrison P; Morrow J; Patterson V
Seizure; 1999 Jun; 8(4):253-4. PubMed ID: 10452927
[No Abstract] [Full Text] [Related]
4. Brief report novel mechanism for valproate-induced teratogenicity.
Fathe K; Palacios A; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2014 Aug; 100(8):592-7. PubMed ID: 25066307
[TBL] [Abstract][Full Text] [Related]
5. Valproic Acid in Women and Girls of Childbearing Age.
Gotlib D; Ramaswamy R; Kurlander JE; DeRiggi A; Riba M
Curr Psychiatry Rep; 2017 Sep; 19(9):58. PubMed ID: 28726062
[TBL] [Abstract][Full Text] [Related]
6. [Morphological changes induced by valproate and its administration concomitant with folinic acid or S-adenosylmethionine in pregnant rats].
Ubeda-Martín N; Alonso-Aperte E; Achón M; Varela-Moreiras G; Puerta J; Pérez de Miguelsanz J
Nutr Hosp; 1998; 13(1):41-9. PubMed ID: 9578686
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation.
Padmanabhan R; Shafiullah MM
Congenit Anom (Kyoto); 2003 Mar; 43(1):29-40. PubMed ID: 12692401
[TBL] [Abstract][Full Text] [Related]
8. Teratogenicity of sodium valproate.
Alsdorf R; Wyszynski DF
Expert Opin Drug Saf; 2005 Mar; 4(2):345-53. PubMed ID: 15794725
[TBL] [Abstract][Full Text] [Related]
9. Why do some women with epilepsy use valproic acid despite current guidelines? A single-center cohort study.
Bosak M; Słowik A; Turaj W
Epilepsy Behav; 2019 Sep; 98(Pt A):1-5. PubMed ID: 31299525
[TBL] [Abstract][Full Text] [Related]
10. Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation.
Yerby MS
Epilepsia; 2003; 44 Suppl 3():33-40. PubMed ID: 12790884
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy A
Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.
Nau H; Hauck RS; Ehlers K
Pharmacol Toxicol; 1991 Nov; 69(5):310-21. PubMed ID: 1803343
[TBL] [Abstract][Full Text] [Related]
13. Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies.
Wilson RD; ; Wilson RD; Audibert F; Brock JA; Carroll J; Cartier L; Gagnon A; Johnson JA; Langlois S; Murphy-Kaulbeck L; Okun N; Pastuck M; ; Deb-Rinker P; Dodds L; Leon JA; Lowel HL; Luo W; MacFarlane A; McMillan R; Moore A; Mundle W; O'Connor D; Ray J; Van den Hof M
J Obstet Gynaecol Can; 2015 Jun; 37(6):534-52. PubMed ID: 26334606
[TBL] [Abstract][Full Text] [Related]
14. Valproate and folate: Congenital and developmental risks.
Reynolds EH; Green R
Epilepsy Behav; 2020 Jul; 108():107068. PubMed ID: 32375098
[TBL] [Abstract][Full Text] [Related]
15. Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?
Jentink J; Bakker MK; Nijenhuis CM; Wilffert B; de Jong-van den Berg LT
Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):803-7. PubMed ID: 20680999
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate increases valproic acid-induced developmental toxicity, in particular neural tube defects in mice.
Elmazar MM; Nau H
Teratog Carcinog Mutagen; 1992; 12(5):203-10. PubMed ID: 1363493
[TBL] [Abstract][Full Text] [Related]
17. [Pregnancy, contraception and epilepsy].
Leppert D; Wieser HG
Nervenarzt; 1993 Aug; 64(8):494-503. PubMed ID: 8413747
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature.
Kozma C
Am J Med Genet; 2001 Jan; 98(2):168-75. PubMed ID: 11223853
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency.
Roy M; Leclerc D; Wu Q; Gupta S; Kruger WD; Rozen R
J Cell Biochem; 2008 Oct; 105(2):467-76. PubMed ID: 18615588
[TBL] [Abstract][Full Text] [Related]
20. Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis.
Wegner C; Nau H
Neurology; 1992 Apr; 42(4 Suppl 5):17-24. PubMed ID: 1574172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
